Spots Global Cancer Trial Database for optical imaging
Every month we try and update this database with for optical imaging cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers | NCT00432471 | Skin Cancer | Optical Imaging | 18 Years - | M.D. Anderson Cancer Center | |
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery | NCT04459065 | Lung Cancer | IRDye800CW-nimo... | 18 Years - 80 Years | University of Saskatchewan | |
Optical Tomography With Ultrasound Guidance | NCT00908609 | Breast Cancer | 18 Years - | UConn Health | ||
VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer | NCT01508572 | Breast Cancer | bevacizumab-IRD... | 18 Years - | University Medical Center Groningen | |
Near-Infrared Autofluorescence With PTH Test Strip as an SOP of Parathyroid in Thyroid Surgery | NCT05684029 | Thyroid Cancer Hypoparathyroid... Optical Imaging | Near-infrared d... PTH test strip | 12 Years - 70 Years | Fujian Medical University | |
Near-Infrared Autofluorescence With PTH Test Strip as an SOP of Parathyroid in Thyroid Surgery | NCT05684029 | Thyroid Cancer Hypoparathyroid... Optical Imaging | Near-infrared d... PTH test strip | 12 Years - 70 Years | Fujian Medical University | |
VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer | NCT01508572 | Breast Cancer | bevacizumab-IRD... | 18 Years - | University Medical Center Groningen | |
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies | NCT04258566 | Hepatocellular ... | Optical Molecul... Indocyanine Gre... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer | NCT00783757 | Breast Cancer | Optical Imaging | 18 Years - | Massachusetts General Hospital | |
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW | NCT02113202 | Adenomatous Pol... | Bevacizumab-IRD... Near infrared f... | 18 Years - 70 Years | University Medical Center Groningen | |
VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer | NCT01508572 | Breast Cancer | bevacizumab-IRD... | 18 Years - | University Medical Center Groningen | |
Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging | NCT04767659 | Breast Cancer F... Chemotherapy Ef... | MAMMOT2 | 18 Years - | IRCCS San Raffaele | |
TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer | NCT00783757 | Breast Cancer | Optical Imaging | 18 Years - | Massachusetts General Hospital | |
Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers | NCT00432471 | Skin Cancer | Optical Imaging | 18 Years - | M.D. Anderson Cancer Center | |
Phase II Panitumumab-IRDye800 in Head & Neck Cancer | NCT04511078 | Head and Neck C... | Panitumumab-IRD... | 18 Years - | University of Alabama at Birmingham | |
Optical Frequency Domain Imaging for Non-melanoma Skin Cancers | NCT01662713 | Non-Melanoma Sk... | OFDI | 18 Years - 80 Years | Massachusetts General Hospital |